Observers See Ominous Trend In '96 Science Budget

Sidebar:Projected Efforts of Congressional Budget Resolution on Nondefense R&D for the years 1995 to 2002. Analysts say funding cuts represent a shift in Congress away from traditionally 'reflexive' support for scientific initiatives Senate and House committees surprised many science-minded Americans last month when-after months of rumored cuts-they decided to sustain funding for nondefense medical and basic research through 1996. Few analysts were surprised, however, when the committees began

Written bySteve Sternberg
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Analysts say funding cuts represent a shift in Congress away from traditionally 'reflexive' support for scientific initiatives

Senate and House committees surprised many science-minded Americans last month when-after months of rumored cuts-they decided to sustain funding for nondefense medical and basic research through 1996. Few analysts were surprised, however, when the committees began to slash funds for energy and environmental research and federal technology-transfer programs.

Re. Dana Rohrabnacher PLAYER: Rep. Dana Rohrabacher (R-Calif) has a new take on science funding.

The Senate has voted on all but one of the 11 science-related appropriations bills. The remaining bill funds the Department of Labor and the Department of Health and Human Services, the parent agency of the National Institutes of Health. Going into the October recess, the measure was stalled by a Senate deadlock over a provision that would rescind a presidential order prohibiting the government from doing business with companies that permanently replace strikers. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies